Candel Therapeutics Inc. Revenue 2020–2022
Candel Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Candel Therapeutics Inc. revenue for the quarter ending September 30, 2022 was 31000, a 0.00% increase year-over-year.
- Candel Therapeutics Inc. revenue for the twelve months ending September 30, 2022 was 124000, a 0.00% increase year-over-year.
- Candel Therapeutics Inc. annual revenue for 2022 was 125000, a 0.00% increase from 2021.
- Candel Therapeutics Inc. annual revenue for 2021 was 125000, a 0.00% increase from 2020.
- Candel Therapeutics Inc. annual revenue for 2020 was 125000.
Candel Therapeutics Inc. (CADL) — Frequently Asked Questions
Candel Therapeutics Inc. (CADL) is a publicly traded US company. It has a market capitalization of $242M. In fiscal 2022 it reported revenue of $125,000 and net income of -$19M. Explore CADL's stock price, financial statements, earnings history, margins and key ratios below.
What is Candel Therapeutics Inc.'s market cap?
Candel Therapeutics Inc. (CADL) has a market capitalization of $242M.
What is the CADL stock price?
CADL trades at $8.40 (+0.66% on the day).
How much revenue does Candel Therapeutics Inc. make?
Candel Therapeutics Inc. reported revenue of $125,000 in fiscal 2022.
Is CADL profitable?
In fiscal 2022, Candel Therapeutics Inc. reported net income of -$19M.